光明中医
光明中醫
광명중의
GUANG MING JOURNAL TRADITIONAL CHINESE MEDICINE
2014年
5期
950-952
,共3页
王苗慧%马鸿斌%孙红旭%杨雪芳
王苗慧%馬鴻斌%孫紅旭%楊雪芳
왕묘혜%마홍빈%손홍욱%양설방
浊毒%清热排毒胶囊%高尿酸血症%血尿酸%黄嘌呤氧化酶%中医药疗法
濁毒%清熱排毒膠囊%高尿痠血癥%血尿痠%黃嘌呤氧化酶%中醫藥療法
탁독%청열배독효낭%고뇨산혈증%혈뇨산%황표령양화매%중의약요법
Qingre Paidu Capsule%Hyperuricemia%serum Uric Acid%Xanthine Oxidase
目的:观察清热排毒胶囊对高尿酸血症大鼠血清尿酸及肝脏黄嘌呤氧化酶活性的影响,探讨其部分作用机理。方法选用健康SPF级SD雄性大鼠48只,随机分成空白组、模型组、别嘌醇组及清热排毒胶囊高、中、低剂量组,各组均予相应药物灌胃7d后,采用腹腔注射次黄嘌呤及皮下注射氧嗪酸钾制备大鼠高尿酸血症模型。检测大鼠血清尿酸( UA)及肝脏黄嘌呤氧化酶活性(XOD)。结果清热排毒胶囊高剂量组大鼠血清UA水平显著降低(P<0.01)。清热排毒胶囊高、低剂量可抑制大鼠肝脏XOD活性,与模型组比较差异具有统计学意义( P<0.05)。结论清热排毒胶囊可通过抑制肝脏黄嘌呤氧化酶活性而降低血清尿酸水平。
目的:觀察清熱排毒膠囊對高尿痠血癥大鼠血清尿痠及肝髒黃嘌呤氧化酶活性的影響,探討其部分作用機理。方法選用健康SPF級SD雄性大鼠48隻,隨機分成空白組、模型組、彆嘌醇組及清熱排毒膠囊高、中、低劑量組,各組均予相應藥物灌胃7d後,採用腹腔註射次黃嘌呤及皮下註射氧嗪痠鉀製備大鼠高尿痠血癥模型。檢測大鼠血清尿痠( UA)及肝髒黃嘌呤氧化酶活性(XOD)。結果清熱排毒膠囊高劑量組大鼠血清UA水平顯著降低(P<0.01)。清熱排毒膠囊高、低劑量可抑製大鼠肝髒XOD活性,與模型組比較差異具有統計學意義( P<0.05)。結論清熱排毒膠囊可通過抑製肝髒黃嘌呤氧化酶活性而降低血清尿痠水平。
목적:관찰청열배독효낭대고뇨산혈증대서혈청뇨산급간장황표령양화매활성적영향,탐토기부분작용궤리。방법선용건강SPF급SD웅성대서48지,수궤분성공백조、모형조、별표순조급청열배독효낭고、중、저제량조,각조균여상응약물관위7d후,채용복강주사차황표령급피하주사양진산갑제비대서고뇨산혈증모형。검측대서혈청뇨산( UA)급간장황표령양화매활성(XOD)。결과청열배독효낭고제량조대서혈청UA수평현저강저(P<0.01)。청열배독효낭고、저제량가억제대서간장XOD활성,여모형조비교차이구유통계학의의( P<0.05)。결론청열배독효낭가통과억제간장황표령양화매활성이강저혈청뇨산수평。
Objective To observe the effect of Qingrepaidu Capsule on serum uric acid and activities of xanthine oxidase in rats with hyperuricemia and explore its parts of mechanism .Methods SPF 48 healthy male SD rats were randomly divided into 6 groups: normal group, model group , allopurinol group , Qingrepaidu capsule high , middle and low dose group .The corresponding drugs were administered by intragastric injection.After 7 days, the rat model of hyperuricemia was established by hypoxanthine and oxonic acid potassium salt . Measured the serum uric acid ( SUA) and the activity of liver xanthine oxidase ( XOD).Results The serum uric acid of Qingrepaidu capsule high dose group were decreased with a significant difference (P<0.01);The activity of liver xanthine oxidase (XOD) was decreased obviously in Qingrepaidu capsule high and low dose group , there was significant difference with the model group (P<0.05).Conclusion Qingrepaidu Capsule can decrease the level of serum uric acid by inhibiting the activity of XOD in the liver .